FindTrial
Sign In

Coronary Artery Disease

An open labelled observational clinical trial to evaluate the combined effect of virechanottara bilwadhi kashaya basti in hrudroga wsr to coranary artery disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090306
Enrollment
20
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I700- Atherosclerosis of aorta

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Pandit Taranath Government Ayurveda Medical college and hospital ballari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of angiographically documented Stable Coronary Artery Disease on treatment Patients with ejection fraction more than 25% Patients of either sex between the age group of 30 to 70 years Patients with Hyperlipidemia and Dyslipidemia Patients with signs and symptoms of Hrudroga Patients who are fit for Snehapana, Virechana and Basti

Exclusion criteria

Exclusion criteria: Patients who don t provide written informed consent. Patients of Congestive Cardiac Failure Patients of Acute Myocardial Ischemia Patients with uncontrolled Hypertension and Diabetes Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in ejection fraction and signs and symptoms of CADTimepoint: Improvement in ejection fraction and signs and symptoms of CAD—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Patil Sushma Balaj

Taranath Government Ayurveda Medical college and hospital

drkendadamath@gmail.com9986916015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026